Post-transplant Cyclophosphamide (PTCy) is associated with superior gvhd-free, relapse-free survival (GRFS) in HLA-mismatched unrelated donor (MMUD) hematopoietic cell transplantation Meeting Abstract

  

Authors:	Jimenez, A. M. J; Perales, M. A.; Devlin, S. M.; Brown, S.; Lekakis, L. J.; Sauter, C. S.; Pereira, D.; Wang, T. P.; Ponce, D. M.; Beitinjaneh, A.; Chinapen, S.; Goodman, M.; Komanduri, K. V.; Shaffer, B. C.
Abstract Title:	Post-transplant Cyclophosphamide (PTCy) is associated with superior gvhd-free, relapse-free survival (GRFS) in HLA-mismatched unrelated donor (MMUD) hematopoietic cell transplantation
Meeting Title:	2022 Tandem Meetings of ASTCT and CIBMTR
Journal Title:	Transplantation and Cellular Therapy
Volume:	28
Issue:	3 Suppl.
Meeting Dates:	2022 Apr 23-26
Meeting Location:	Salt Lake City, UT
ISSN:	2666-6375
Publisher:	Elsevier Inc.
Date Published:	2022-03-01
Start Page:	S315
End Page:	S316
Language:	English
DOI:	10.1016/S2666-6367(22)00566-8
PROVIDER:	manual
Notes:	Meeting Abstract: 406 -- Located within the section named "Poster Session - Graft-Versus-Host And Graft-Versus-Tumor - Clinical Prevention, Treatment And Biomarkers"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/196989